Bacsan, Jovelyn O.
HRN: 07-94-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2022
CEFTAZIDIME 1GM (VIAL)
04/25/2022
05/02/2022
IV
1g
Q8H
Pneumonia, Moderate Risk
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes